MA10-MA50 Bull Crossover Stocks: Akari Therapeutics (AKTX), Blackberry Limited (BBRY), Fibria Celulose S.A. (FBR), HCP Inc (HCP)

NASDAQ: AKTX (Akari Therapeutics)

NASDAQ: AKTX (Akari Therapeutics) has closed at $11.07, its traded Volume was 14646.9K shares, AKTX opened the Day at $9.2, it made an intraday Low of $8.23, and an intraday High of $11.2. AKTX (Akari Therapeutics) 52-week High is $19.285, 52-week Low is: $6.22, it has supports at $8.11 and $6.21, resistances at $11.19 and $13.06. AKTX’s earning is $-0.29 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -38. Overall, this stock is rated BUY today.

NASDAQ: BBRY (Blackberry Limited)

NASDAQ: BBRY (Blackberry Limited) has closed at $7.75, its traded Volume was 2.73473e+006K shares, BBRY opened the Day at $7.52, it made an intraday Low of $7.47, and an intraday High of $8.08. BBRY (Blackberry Limited) 52-week High is $8.46, 52-week Low is: $6.23, it has supports at $7.19 and $6.65, resistances at $8.07 and $9.42. BBRY’s earning is $-2.71 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -3. Overall, this stock is rated BUY today.

NYSE: FBR (Fibria Celulose S.A.)

NYSE: FBR (Fibria Celulose S.A.) has closed at $9.14, its traded Volume was 1793.51K shares, FBR opened the Day at $9.04, it made an intraday Low of $8.98, and an intraday High of $9.28. FBR (Fibria Celulose S.A.) 52-week High is $10.24, 52-week Low is: $5.79, it has supports at $8.83 and $7.98, resistances at $10.22 and $11.93. FBR’s earning is $0.94 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 10. Overall, this stock is rated BUY today.

NYSE: HCP (HCP Inc)

NYSE: HCP (HCP Inc) has closed at $31.28, its traded Volume was 3785.39K shares, HCP opened the Day at $31.03, it made an intraday Low of $31.01, and an intraday High of $31.38. HCP (HCP Inc) 52-week High is $35.933, 52-week Low is: $27.277, it has supports at $30.51 and $29, resistances at $32.97 and $38.5. HCP’s earning is $1.34 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 23. Overall, this stock is rated BUY today.